Curetis, a Germany-based medical device company, has raised €12.5m ($15m) in its series B round from a consortium including Switzerland-based drugs company Roche’s corporate venturing unit. Alongside Roche Venture Fund in the B round, were investment firm HBM Partners (founded by Henri B Meier, a former member of the Roche Group executive committee for more than…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
